__timestamp | Galapagos NV | Lantheus Holdings, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 69368000 | 301600000 |
Thursday, January 1, 2015 | 39563000 | 293461000 |
Friday, January 1, 2016 | 129517000 | 301853000 |
Sunday, January 1, 2017 | 127087000 | 331378000 |
Monday, January 1, 2018 | 288836000 | 343374000 |
Tuesday, January 1, 2019 | 844986000 | 347337000 |
Wednesday, January 1, 2020 | 478053000 | 339410000 |
Friday, January 1, 2021 | 484846000 | 425208000 |
Saturday, January 1, 2022 | 505280000 | 935061000 |
Sunday, January 1, 2023 | 239724000 | 1296429000 |
Unveiling the hidden dimensions of data
In the competitive landscape of the healthcare industry, revenue generation is a key indicator of a company's market position and growth potential. Over the past decade, Lantheus Holdings, Inc. and Galapagos NV have been vying for dominance. From 2014 to 2023, Lantheus Holdings consistently outperformed Galapagos NV, with a notable revenue surge in 2023, reaching approximately 1.3 billion USD, nearly doubling its 2022 figures. In contrast, Galapagos NV peaked in 2019 with a revenue of around 845 million USD but has since seen a decline, dropping to about 240 million USD in 2023. This trend highlights Lantheus Holdings' robust growth strategy and market adaptability, while Galapagos NV faces challenges in maintaining its revenue momentum. As the industry evolves, these companies' financial trajectories offer valuable insights into their strategic directions and market resilience.
Breaking Down Revenue Trends: Eli Lilly and Company vs Lantheus Holdings, Inc.
Revenue Insights: Teva Pharmaceutical Industries Limited and Galapagos NV Performance Compared
BeiGene, Ltd. or Lantheus Holdings, Inc.: Who Leads in Yearly Revenue?
Comparing Revenue Performance: Incyte Corporation or Lantheus Holdings, Inc.?
Bio-Techne Corporation and Galapagos NV: A Comprehensive Revenue Analysis
Comparing Revenue Performance: BioMarin Pharmaceutical Inc. or Lantheus Holdings, Inc.?
Breaking Down Revenue Trends: Pharming Group N.V. vs Galapagos NV
Comparing Revenue Performance: Lantheus Holdings, Inc. or Xencor, Inc.?
Grifols, S.A. vs Galapagos NV: Examining Key Revenue Metrics
TG Therapeutics, Inc. or Galapagos NV: Who Leads in Yearly Revenue?
Revenue Insights: Bausch Health Companies Inc. and Galapagos NV Performance Compared
Revenue Insights: Geron Corporation and Galapagos NV Performance Compared